Clinical Trials Directory

Trials / Completed

CompletedNCT03084367

Physiologic Assessment of Coronary Stenosis Following PCI

DEFINE PCI: Physiologic Assessment of Coronary Stenosis Following PCI

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Volcano Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).

Detailed description

DEFINE-PCI is a multi-center, prospective, non-significant risk study in up to 25 centers in USA and internationally. Consented subjects with CAD (Coronary Artery Disease) who undergo physiologic lesion assessment with iFR\<0.90 in at least 1 coronary artery are eligible for participation. After successful PCI to all culprit lesions based on angiographic assessment of the treating physician, a blinded post-PCI iFR and iFR pullback will be performed. The proportion of patients with impaired post-PCI iFR will be assessed, and the number of patients in whom ischemia could theoretically be normalized with further PCI determined. Additionally, the association between the post-PCI iFR results and cardiovascular events and clinical symptoms will be assessed. Follow-up will be at 1, 6 and 12 months, including administration of quality of life questionnaires.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTiFR pullbackiFR pullback assessment post angiographically successful PCI

Timeline

Start date
2017-06-20
Primary completion
2019-01-18
Completion
2020-02-18
First posted
2017-03-20
Last updated
2022-05-10
Results posted
2022-05-10

Locations

28 sites across 3 countries: United States, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT03084367. Inclusion in this directory is not an endorsement.